Publications
Export 25 results:
Filters: Keyword is Parkinson Disease [Clear All Filters]
, “Parkinson's Disease-Linked LRRK2-G2019S Mutation Alters Synaptic Plasticity and Promotes Resilience to Chronic Social Stress in Young Adulthood.”, J Neurosci, vol. 38, no. 45, pp. 9700-9711, 2018.
, “Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b.”, FEBS Lett, vol. 589, no. 24 Pt A, pp. 3727-38, 2015.
, “Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.”, Curr Biol, vol. 25, no. 18, pp. 2349-60, 2015.
, “Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.”, Clin Linguist Phon, vol. 29, no. 6, pp. 424-40, 2015.
, “Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.”, Neurobiol Aging, vol. 35, no. 1, pp. 223-31, 2014.
, “Social perception in adults with Parkinson's disease.”, Neuropsychology, vol. 28, no. 6, pp. 905-16, 2014.
, “[Are non-literal language comprehension deficits related to a theory of mind deficit in Parkinson's disease?].”, Geriatr Psychol Neuropsychiatr Vieil, vol. 11, no. 2, pp. 208-14, 2013.
, “Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.”, Biochem Pharmacol, vol. 86, no. 7, pp. 970-8, 2013.
, “The heterogeneity of cognitive symptoms in Parkinson's disease: a meta-analysis.”, J Neurol Neurosurg Psychiatry, vol. 84, no. 11, pp. 1265-72, 2013.
, “The role of basal ganglia in language production: evidence from Parkinson's disease.”, J Parkinsons Dis, vol. 3, no. 3, pp. 393-7, 2013.
, “Parkinson's disease: acquired frailty of archaic neural networks?”, J Neurol Sci, vol. 314, no. 1-2, pp. 143-51, 2012.
, “Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.”, Parkinsonism Relat Disord, vol. 17, no. 8, pp. 593-8, 2011.
, “Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.”, Ann Neurol, vol. 68, no. 5, pp. 619-28, 2010.
, “Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.”, Can J Neurol Sci, vol. 37, no. 3, pp. 313-9, 2010.
, “Irony comprehension and theory of mind deficits in patients with Parkinson's disease.”, Cortex, vol. 45, no. 8, pp. 972-81, 2009.
, “L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network.”, PLoS One, vol. 4, no. 7, p. e6154, 2009.
, “Understanding speaker attitudes from prosody by adults with Parkinson's disease.”, J Neuropsychol, vol. 2, no. Pt 2, pp. 415-30, 2008.
, “Vocal emotion processing in Parkinson's disease: reduced sensitivity to negative emotions.”, Brain Res, vol. 1188, pp. 100-11, 2008.
, “Dopaminergic neurons intrinsic to the striatum.”, J Neurochem, vol. 101, no. 6, pp. 1441-7, 2007.
, “Effects of verbal working memory deficits on metaphor comprehension in patients with Parkinson's disease.”, Brain Lang, vol. 101, no. 1, pp. 80-9, 2007.
, “The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.”, Brain, vol. 130, no. Pt 1, pp. 222-32, 2007.
, “GABAergic interneurons in human subthalamic nucleus.”, Mov Disord, vol. 20, no. 5, pp. 574-84, 2005.
, “Novel aspects of the chemical anatomy of the striatum and its efferents projections.”, J Chem Neuroanat, vol. 26, no. 4, pp. 271-81, 2003.
, “Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.”, Ann Neurol, vol. 54, no. 5, pp. 599-604, 2003.
, “Jules Bernard Luys: a singular figure of 19th century neurology.”, Can J Neurol Sci, vol. 29, no. 3, pp. 282-8, 2002.
